Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1989-11-16
1991-08-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A01N 4500, C07J17200
Patent
active
050396714
ABSTRACT:
26, 26, 26-Trifluoro-1.alpha., 25-dihydroxy-cholecalciferol, and the 25R or 25S epimer thereof, are described, as well as processes and intermediates utilized to prepare the same, as well as pharmaceutical compositions containing the same. 26,26,26-trifluoro 1.alpha., 25-dihydroxycholecalciferol and the 25R or 25S epimer thereof are useful agents in the treatment of disease states such as osteoporosis, oseodystrophy and leukemia.
REFERENCES:
patent: 4229358 (1980-10-01), DeLuca et al.
patent: 4391802 (1983-07-01), Suda et al.
patent: 4906785 (1990-03-01), Baggiolini et al.
Proceedings of the Fifth Workshop on Vitamin D 1982, p. 1079-1084.
Koeffler et al. Cancer Research, 44,5624-5628, Dec. 1984.
Dokah, S. et al., Endocrinology 112:200-206, 1983.
Murao, S. Cancer Research 43(8):4989-4996, 1983.
Reitsma P. et al., J. Cell. Biol. 97(5):347a, 1983.
Rigby, W. F. C. et al., Blood 62(5):153a, 1983.
Olsson, I. and Lund, U., Cancer Research 43 5862-5867, 1983 Eisman, J. A. et al., Lancet, Dec. 22/29:1335-1336, 1979.
Frampton, R. J. et al., Cancer Research 42:1116-1119, 1982.
Colston, K. et al., Cancer Research 42:856-859, 1982.
Sher, E. et al., Biochem. 200: 315-320, 1981.
Frampton, R. J. et al., Cancer Research 43:4443-4447, 1983.
Shiina, Y. et al., Arch Biochem. Biophys 220:90-94, 1983.
Abe, E. et al., Proc. Natl. Acad. Sci. U.S.A. 78:4990-4994, 1981.
McCarthy, D., Exp. Hematol 11 (Suppl. 14):200, 1983.
Honma Y. et al., Proc. Natl., Acad. Sci. U.S.A. 80:201-204, 1983.
Sato, T. et al., Tohoku J. Exp. Med. 138:445-446, 1982.
McCarthy, D. M. et al., Lancet Jan. 14:78-80, 1984.
Kobayashi et al., Tetrahedron, vol. 22, No. 43, pp. 4309-4312, (1981).
Baggiolini Enrico G.
Pizzolato Giacomo
Truitt Gary A.
Uskokovic Milan R.
Ciambrone Coletti Ellen
Criares T. J.
Gould George M.
Hoffmann-La Roche Inc.
Leon Bernard S.
LandOfFree
Trifluorinated-1.alpha.,25S-dihydroxy vitamin D3 compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trifluorinated-1.alpha.,25S-dihydroxy vitamin D3 compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trifluorinated-1.alpha.,25S-dihydroxy vitamin D3 compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1527436